Development of the patient experience questionnaire for parents of pediatric patients (PEQP)
Permalink
Citation
Kaipio , J , Karisalmi , N , Hiekkanen , K , Stenhammar , H & Lahdenne , P 2019 , Development of the patient experience questionnaire for parents of pediatric patients (PEQP) . in F Lau , J A Bartle-Clar , G Bliss , E M Borycki , K L Courtney , A M-H Kuo , A Kushniruk , H Monkman & A V Roudsari (eds) , Improving Usability, Safety and Patient Outcomes with Health Information Technology . Studies in Health Technology and Informatics , vol. 257 , IOS PRESS , Amsterdam , pp. 200-205 , Information Technology & Communications in Health , Victoria , Canada , 14/02/2019 . https://doi.org/10.3233/978-1-61499-951-5-200
| Title: | Development of the patient experience questionnaire for parents of pediatric patients (PEQP) |
| Author: | Kaipio, Johanna; Karisalmi, N.; Hiekkanen, K.; Stenhammar, H.; Lahdenne, P. |
| Other contributor: |
University of Helsinki, HUS Children and Adolescents
Lau, Francis Bartle-Clar, John A. Bliss, Gerry Borycki, Elizabeth M. Courtney, Karen L. Kuo, Alex Mu-Hsing Kushniruk, Andre Monkman, Helen Roudsari, Abdul Vahabpour |
| Publisher: | IOS PRESS |
| Date: | 2019 |
| Language: | eng |
| Number of pages: | 6 |
| Belongs to series: | Improving Usability, Safety and Patient Outcomes with Health Information Technology |
| Belongs to series: | Studies in Health Technology and Informatics |
| ISBN: | 978-1-61499-950-8 978-1-61499-951-5 |
| DOI: | https://doi.org/10.3233/978-1-61499-951-5-200 |
| URI: | http://hdl.handle.net/10138/327656 |
| Abstract: | Patient experience (PX) is an important evaluation criterion for quality in healthcare. Compared to patient satisfaction, however less research has focused on the development of instruments to measure experiences of patients and their families. In the article, we describe the process of developing a PX questionnaire for the parents of pediatric patients in the context of children's hospital and illustrate the questionnaire items for measuring PX. The phases of the development process included retrospective interviews, description of the themes influencing PX and the metrics for measuring PX, as well as iterative development of three versions of questionnaires including data gathering and factor analysis. The final versions of the surveys suggested for implementation at the hospitals include eight PX statements for the outpatient clinic and five statements for the ward. Compared to satisfaction surveys, the developed surveys emphasize the aspects of parent's attitude towards the illness, support for families, and daily arrangements with a child patient. © 2019 American Psychological Association Inc. All rights reserved. |
| Subject: |
children's hospital
measurement parent patient experience pediatric patient questionnaire Hospitals Measurement Pediatrics Quality control Development process Evaluation criteria Iterative development Patient experiences Patient satisfaction Pediatric patients Surveys article child clinical article controlled study factor analysis female human interview male outpatient department satisfaction adult child parent relation hospital patient satisfaction patient-reported outcome retrospective study Adult Child Factor Analysis, Statistical Hospitals, Pediatric Humans Parents Patient Reported Outcome Measures Patient Satisfaction Retrospective Studies Surveys and Questionnaires 3123 Gynaecology and paediatrics |
| Rights: |
Files in this item
Total number of downloads: Loading...
| Files | Size | Format | View |
|---|---|---|---|
| SHTI257_0200.pdf | 292.8Kb |
View/ |
This item appears in the following Collection(s)
-
Articles from TUHAT CRIS [40320]
Related items
Showing items related by title, author, creator and subject.
-
(2018)Background: Data on the immunization practices in pediatric chronic kidney disease (CKD) patients are scarce. The purpose of this study was to evaluate current vaccination practices for children on dialysis across European pediatric nephrology centers. Methods: A total of 18 tertiary pediatric nephrology centers from 12 European countries were included in the study. The data on universal national immunization programs and immunization practices for children with chronic disease or risk were recorded from European Center for Disease Prevention and Control and the World Health Organization. The immunization practices and center protocols for monitoring antibody titers after vaccination in dialysis patients were obtained through a questionnaire. Results: All centers included in the study recommended immunization against hepatitis B virus (HBV), diphtheria, tetanus, pertussis, Hemophilus influenzae type b (Hib), poliomyelitis, measles, mumps, rubella (MMR), and streptococcus pneumonia in dialysis patients. In 16 centers, dialysis patients were vaccinated against influenza virus annually. HBV protective antibody titers were measured in 17 centers (during dialysis period in 14 centers, during pre-renal transplantation preparations in 14 centers or in both times in 11 centers). Hepatitis A virus (HAV) was reported to be followed in 13 centers, in 8 centers during dialysis period, and in 11 centers during pre-RTx preparations. MMR and varicella-zoster virus (VZV) protective antibody titers were measured during the dialysis period or before renal transplantation (RTx) in 12 and 15 centers, respectively, and in 6 centers both titers were checked both times. Conclusion: There are variations in vaccination practice across Europe. Children with CKD, those undergoing dialysis, and transplant candidates should receive age-appropriate vaccinations before RTx as well as before the transition to adult nephrology clinics and antibody levels should be monitored to evaluate the immunization status before and after RTx. (C) 2017 S. Karger AG, Basel.
-
(2020)Introduction Spermatic cord torsion (SCT) may lead to organ loss and can potentially influence fertility. Long-term effects of SCT are not fully investigated. Objective The purpose was to evaluate paternity rates in adults who have had SCT in childhood and to compare the results to those of a control population. The secondary purposes were to compare paternity rates after testis-preserving surgery with those after orchiectomy and to evaluate erectile function and health-related quality of life (HRQoL). Study design Questionnaires concerning paternity, erectile function (International Index of Erectile Function [IIEF]-5 questionnaire), and HRQoL (15D questionnaire) were mailed to 74 men who had been treated for SCT and to 92 controls treated for testicular appendage torsion in 1977-1995 and who were currently older than 30 years. Results Thirty-five of the 74 (47%) patients with SCT and 58 of the 92 (63%) controls responded. A same-aged control was selected for each patient with SCT. The median age at investigation was 41 (interquatile range [IQR]: 36 to 46) years in the SCT group and 41 (IQR: 38 to 46) years in the control group (p = 0.81). The paternity rate was 23 of 35 (66%) in the SCT group and 26 of 34 (76%) in the control group (p = 0.43). Nine percent of patients and controls suffered from infertility. Of the 30- to 50-year-old patients with SCT, 9 of 16 (56%) had children after orchiectomy, and 13 of 16 (81%), after detorsion (p = 0.25). Significant or moderate erectile dysfunction (IIEF-5 total score Discussion Paternity, erectile function, or HRQoL was not impaired in the general level in the patients with SCT in comparison with controls. Both the modes of treatment, orchiectomy or detorsion, had no significant impact on the results. However, the results cannot be generalized to the individual level. The limitations were a small sample size and inability to investigate maternal factors to the paternity. However, the results are encouraging for the patients and families. Conclusion Paternity rate and HRQoL were similar in patients with SCT and controls. The type of surgery (orchiectomy vs. detorsion) did not affect paternity rates statistically. Moderate or significant erectile dysfunction was rare in both groups.
-
(2019)Background Supportive-care use of granulocyte colony-stimulating factor (G-CSF) in pediatric acute myeloid leukemia (AML) remains controversial due to a theoretical increased risk of relapse and limited impact on neutropenic complications. We describe the use of G-CSF in patients treated according to NOPHO-AML 2004 and DB AML-01 and investigated associations with relapse. Procedure Patients diagnosed with de novo AML completing the first week of therapy and not treated with hematopoietic stem cell transplantation in the first complete remission were included (n = 367). Information on G-CSF treatment after each course (yes/no) was registered prospectively in the study database and detailed information was gathered retrospectively from each center. Descriptive statistics were used to describe G-CSF use and Cox regression to assess the association between G-CSF and risk of relapse. Results G-CSF as supportive care was given to 128 (35%) patients after 268 (39%) courses, with a large variation between centers (0-93%). The use decreased with time-the country-adjusted odds ratio was 0.8/diagnostic year (95% confidence interval [CI] 0.7-0.9). The median daily dose was 5 mu g/kg (range 3-12 mu g/kg) and the median cumulative dose was 75 mu g/kg (range 7-1460 mu g/kg). Filgrastim was used in 82% of G-CSF administrations and infection was the indication in 44% of G-CSF administrations. G-CSF was associated with increased risk of relapse-the adjusted hazard ratio was 1.5 (95% CI 1.1-2.2). Conclusions G-CSF as supportive care was used in a third of patients, and use decreased with time. Our results indicate that the use of G-CSF may be associated with an increased risk of relapse.
